Physician
Endocrinology
Dr. Willa A. Hsueh, MD
|
|
Give Review
Dr. Willa A. Hsueh works in the field of Endocrinology. She went to medical school at The Ohio State University College of Medicine. She has 3 awards "America's Top Doctors", "Women's Health" and "Men's Health". Willa Hsueh is a published doctor. She has 67 publications published. The most current publication "Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome." She accepts Medicare.
Publications
- Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome.
- Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation.
- Mechanical Unloading Promotes Myocardial Energy Recovery in Human Heart Failure.
- High fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.
- Systematic evaluation of validated type 2 Diabetes and glycaemic trait loci for association with insulin clearance.
- Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepati...
- Class II Major Histocompatibility Complex Plays an Essential Role in Obesity-Induced Adipose Inflammation.
- Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.
- Efficacy of amlodipine/olmesartan medoxomilZ in obese patients uncontrolled on antihypertensive monotherapy.
- Thyroid Hormone Receptor Agonists Reduce Serum Cholesterol Independent of the LDL Receptor.
- The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway.
- A peroxisome proliferator activated receptor (PPAR) {gamma}/PPAR{gamma} coactivator 1{beta} autoregulatory loop in adipocyte mitochondrial function.
- A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochl...
- Fasting Insulin Reflects Heterogeneous Physiologic Processes: Role of Insulin Clearance.
- Renin-Angiotensin-aldosterone system in Diabetes and hypertension.
- Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
- PreDiabetes: the importance of early identification and intervention.
- Critical role for osteopontin in diabetic nephropathy.
- MicroRNA-integrated and network-embedded gene selection with diffusion distance.
- Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
- Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.
- A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle Cells.
- Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic synd...
- Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
- Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project.
- PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.
- SORCS1: a novel human type 2 Diabetes susceptibility gene suggested by the mouse.
- Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-...
- A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
- Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in Diabetes.
- Genetic effects on obesity assessed by bivariate genome scan: the Mexican-American coronary artery disease study.
- The predictive role of blood glucose for mortality in subjects with cardiovascular disease.
- Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 Diabetes.
- Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosph...
- Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II.
- Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance.
- The role of thiazolidinediones in reversing insulin resistance and altering coronary vasomotor function.
- The role of thiazolidinediones in reversing insulin sensitivity and altering endothelial dysfunction.
- The 3' untranslated region of the lipoprotein lipase gene: haploType structure and association with post-heparin plasma lipase activity.
- Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 Diabetes mellitus.
- Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
- Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
- Association of the Diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.
- Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.
- A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study.
- Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
- C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells.
- Genetic markers: progress and potential for cardiovascular disease.
- Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
- Coronary vasomotor abnormalities in insulin-resistant individuals.
- Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease.
- Lipoprotein lipase is a gene for insulin resistance in Mexican Americans.
- Effect of plasminogen activator inhibitor-1 in Diabetes mellitus and cardiovascular disease.
- Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.
- Introduction: New insight into understanding the relation of type 2 Diabetes mellitus, insulin resistance, and cardiovascular disease.
- Role of endothelial dysfunction in insulin resistance.
- The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease.
- Determination and use of haploTypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans.
- Minireview: adiposity, inflammation, and atherogenesis.
- PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4.
- TGF-beta(1) induces peroxisome proliferator-activated receptor gamma1 and gamma2 expression in human THP-1 monocytes.
- Synthetic LXR ligand inhibits the development of atherosclerosis in mice.
- Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent.
- Vascular protective effects by activation of nuclear receptor PPARgamma.
- Therapeutic interventions to reduce the risk of progression from preDiabetes to type 2 Diabetes mellitus.
- Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein choleste...
Schools
Ohio State University College of Medicine
Johns Hopkins Hospital
Conditions Treated
- Diabetes Type 2
- Goiter
- Hypothyroidism
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- America's Top Doctors
- Women's Health
- Men's Health
Education
-
Johns Hopkins University -
The Ohio State University College of Medicine
Drug Facts
| NPI NUMBER | 1023036076 | |
| NPPES Provider LastName | HSUEH | |
| NPPES Provider FirstName | WILLA | |
| NPPES Provider ZIPCode | 432031278 | |
| NPPES Provider State | OH | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023036076 |
| Last Name Of The Provider | HSUEH |
| First Name Of The Provider | WILLA |
| View All |
Similar Doctors
|
Dr. John D. Blackman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura E. Ryan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dara P. Schuster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daryl A. Cottrell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie K. Hoffman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rundsarah M. Tahboub, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kwame Osei, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Susannah M. Becker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria J. Henwood-Finley, DO |
|
|
Dr. Shumei Meng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rajaram J. Karne, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nora Alghothani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence S. Kirschner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|